HSP90B2P and skin basal cell carcinoma: Last, our results suggest that BCC tumors may respond to inflammatory signals from the stroma by expressing HSPs and that HSP inhibitors may serve as an effective therapeutic strategy to suppress HH signaling and tumor growth.